A new less-invasive coronavirus test is being fast tracked as the FDA is granting emergency use authorization for a saliva test.

The National Basketball Association helped fund the development of the test. They use it to test for non-symptomatic carriers.

Health experts say it could help parts of the country where the infection rate continues to rise. "It doesn't need the same re-agents and swabs that have been the limiting steps to create testing at scale in this country. It really could be a game changer if we can deploy it," says Dr. Abdul El-Sayed, epidemiologist and public health expert.

Officials say results can be determined in under three hours.

Tests are expected to cost about $10 per sample.